Jamie Dimons Latest Message May Signal Challenges for JPMorgan Bankers Michael Saylor Tokenization Could Create Free Market for Credit Challenge Traditional Banking Huawei Advances Chip Design Method Amid US Restrictions Plans New Smartphone Chips This Fall Gamers Who Fueled Nvidias Rise Face Higher Costs as AI Demand Reshapes Tech Priorities Market Expectations Suggest SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaway in Potential Public Debut Valuations OpenRouter Secures 113M to Streamline Enterprise AI Inference Routing CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158 Chesapeake Utilities Corporation Q1 2026 Earnings Earnings Beat Expectations Stock Slips Slightly Phreesia PHR Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Progress ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development BLFY Q3 2025 Earnings NarrowerthanExpected Loss Despite EPS Miss Hinge Health HNGE Drops 41 Approaches Key Support at 5033 A SPAC III Acquisition Corp ASPC Holds Steady at 1085 as Investors Await Business Combination SM Energy Slips 26 as Selling Pressure Mounts Key Support Levels in Focus BGSF Inc BGSF Slides 323 as Selling Pressure Intensifies Below Resistance Duoloinco Edges Higher as Language Learning Platform Holds Above Key Support EU and Mexico Strengthen Trade Alliance to Reduce Dependence on Major Economies AnheuserBusch InBev Shares Decline After Sales Miss Market Expectations Inflation Rate Projected to Hit 6 in Second Quarter Top Economic Forecasters Say IRS Settlement Blocks Tax Audits on Trump and Family Implications for Financial Oversight Treasury Yield Surge Prompts Bond Investors to Explore Alternatives Beyond RiskFree Assets US Treasury Yield Surge Reshapes Risk Perceptions for Bond Investors Fed Dissenters Explain No Votes Citing Concerns Over Forward Guidance on Rate Cuts PNTG Q1 2026 Earnings EPS Beats Estimates Slightly as Stock Declines MannKind Corporation MNKD Surges 44 Testing Key Resistance Amid Biotech Momentum